Promoting Innovation - Protecting the Public Domain 

We evaluate pharmaceutical patents for validity, challenge non-meritorious patents to ensure access to affordable medicines, and help you make informed decisions

I-MAK assesses IP obstacles for health crises such as avian flu, HIV, and malaria, to facilitate informed decision-making for procurement for public benefit

 

I-MAK Delivers a New, Evidence-Based Approach to Intellectual Property & Access to Treatment